Related Experiment Video
Updated: Mar 8, 2026
06:22
Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome ARDS
Published on: April 7, 2021
3.9K
Sympathetic crashing acute pulmonary edema
Naman Agrawal1, Akshay Kumar1, Praveen Aggarwal1
1Department of Emergency Medicine, All India Institute of Medical Sciences, New Delhi, India.
Summary
Sympathetic crashing acute pulmonary edema (SCAPE) is a severe condition. Prompt treatment with noninvasive ventilation and nitrates improves outcomes, while morphine and diuretics lack evidence.
Area of Science:
- Cardiology
- Emergency Medicine
- Pulmonology
Background:
- Sympathetic crashing acute pulmonary edema (SCAPE) represents a critical form of acute pulmonary edema.
- It is frequently encountered in emergency departments and necessitates prompt recognition and management.
- Understanding SCAPE is crucial for improving patient outcomes.
Purpose of the Study:
- To highlight the importance of timely and effective management of SCAPE.
- To emphasize the primary treatment modalities for SCAPE.
- To address the efficacy of commonly used but less evidence-based treatments.
Main Methods:
- Review of clinical presentation and management strategies for SCAPE.
- Emphasis on the immediate application of evidence-based therapies.
- Discussion of the limited scientific support for certain traditional treatments.
Main Results:
- SCAPE is characterized by rapid fluid redistribution within the lungs.
- Effective and prompt treatment leads to rapid patient recovery.
- Noninvasive ventilation and intravenous nitrates are the cornerstone of successful SCAPE management.
Conclusions:
- Early initiation of noninvasive ventilation and intravenous nitrates is vital for SCAPE patients.
- Morphine and intravenous loop diuretics, despite common use, have limited scientific backing for SCAPE.
- Appropriate and timely management significantly improves prognosis in SCAPE.
Related Concept Videos
01:29Pulmonary Embolism I: Introduction
1.0K
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
1.0K
01:26Heart Failure III: Clinical Manifestations
749
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
749
01:23Acute Respiratory Failure-IV
655
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
655
01:30Acute Respiratory Failure-III
1.0K
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
1.0K
01:27Pneumothorax-II
1.2K
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
1.2K
01:21Acute Respiratory Failure-II
1.3K
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.3K